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A B S T R A C T
Objective: To investigate whether restless legs syndrome (RLS) is associated with impaired physical func-
tioning using subjective and objective assessments.
Methods: From 2006–2013, 5,960 participants (mean age 67.2; 57.5% females) of the prospective population-
based Rotterdam Study, aged 45 years and over, were cross-sectionally investigated for presence of restless
legs syndrome using a questionnaire. Physical functioning was assessed subjectively with the Stanford
Health Assessment Questionnaire (basic activities of daily living) and the Instrumental Activities of Daily
living scale (instrumental activities of daily living). Additionally, physical functioning was assessed ob-
jectively by quantifying ﬁne motor performance with the Purdue Pegboard Test and by quantifying gait
with an electronic walkway.
Results: Restless legs syndrome was present in 13.7% of the participants. Persons with restless legs had
more impairment in basic (difference in score 0.65, 95% CI 0.41;0.90) and instrumental activities of daily
living (difference in score 0.28, 95% CI 0.09;0.48) than persons without restless legs. This association was
strongest when symptoms were present two or more times a week (basic activities of daily living score
difference 1.69, 95% CI 1.28;2.09). The association between restless legs syndrome and activities of daily
living attenuated after adjusting for sleep quality or depressive symptoms. There was no association with
the Purdue Pegboard Test score nor with gait.
Conclusions: Individuals with restless legs syndrome experienced signiﬁcantly more impairment in ac-
tivities of daily function than persons without restless legs. This seemed to be (partly) mediated by poor
sleep quality and depressive symptoms. No association was found with objectively assessed physical
functioning.
© 2016 Elsevier B.V. All rights reserved.
1. Introduction
Restless legs syndrome (RLS) is a sensorimotor disorder char-
acterized by uncomfortable leg sensations and an urge to move the
legs, which may also affect arms and other body parts. RLS pa-
tients often experience motor symptoms such as rhythmic
movements of the legs, called periodic limb movements [1]. Prev-
alence of RLS varies from 1% to 15% among different ethnic
populations [2]. The pathophysiology of RLS is not completely un-
derstood. Changes in ironmetabolism and subsequent dopaminergic
dysfunction probably play an important role in the pathophysiol-
ogy of the disease, but the exact mechanisms remain unclear [3–5].
Other factors that have been associated with RLS include gender,
pregnancy, body mass index (BMI), diabetes mellitus, renal failure
and socio-economic status [2,3,6–12].
Althoughmost RLS symptoms occur at night, several studies have
revealed the impact of RLS on daily functioning. Problems not only
include daytime sleepiness and concentration diﬃculties, which can
be attributed to sleep disruption, but also physical dysfunction, which
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involves both arms and legs [2,7,11,13–21]. Whereas previously as-
sessed physical functioning was mainly self-reported and thus
subjective, more objective measures can be obtained by quantify-
ingmotor performance. Functioning of the legs can be assessed using
electronic walkways that quantify gait [22,23], while functioning
of the arms can be assessed with tests for manual dexterity, such
as the Purdue Pegboard Test [24]. Indeed, several studies have shown
these objective measurements to capture various aspects of self-
reported physical functioning [25–30]. However, little is known on
the association of RLS with these objective measurements. The un-
derlying mechanism linking RLS with motor performance includes
dopamine dysregulation and altered circuitry of the motor cortex
[3,4,31]. Additionally, whether impaired performance of daily tasks
in patients with RLS is a result of often accompanied sleep or mood
disorders, or is a direct result of the pathophysiological changes in
RLS leading to diminished motor function remains unclear.
We investigated the associations of RLSwith subjectively assessed
daily functioning, using activities of daily living (ADL) questionnaires
and with objectively assessed motor performance using tests for gait
and manual dexterity.
2. Material and methods
2.1. Study setting
This study was embedded in the Rotterdam Study, a prospec-
tive population-based cohort study in the Netherlands. The main
aim of this study is to investigate causes of chronic diseases in the
elderly [32]. The study started in 1990 and was expanded in 2000
and 2006. Over the years, 14,926 participants have been enrolled
in the Rotterdam Study. All inhabitants of the Ommoord district of
Rotterdam who were 55 years or older were selected from the mu-
nicipal population register and invited to participate in the study.
In 2006, people above the age of 45 years were invited. There were
no other selection criteria. At baseline and every three to four years
of follow-up, all participants undergo a home interview and a com-
prehensive set of examinations at the research center. Participants
are invited for these follow-up assessments in a random order. From
2006 onwards the home interview was extended with a RLS
questionnaire.
The Rotterdam Study has been approved by the medical ethics
committee according to the Wet Bevolkingsonderzoek ERGO (Pop-
ulation Study Act Rotterdam Study), executed by the ministry of
Health, Welfare and Sports of the Netherlands. Written informed
consent was obtained from all participants.
2.2. Population for analysis
Between August 2006 and May 2013 6,431 participants were in-
terviewed.We excluded participantswho hadmissing data concerning
either the RLS (106 participants) or the ADL questionnaires (72 par-
ticipants). We excluded 71 participants because they were demented
and 204 participants because they were not suﬃciently screened for
dementia. The ﬁnal study population consisted of 5,960 participants.
Gaitwas only assessed betweenMarch 2009 andDecember 2011, after
implementationof an electronicwalkway.Of the5,960participantswith
RLS and ADL data, 2,548 had complete gait data available. Data on the
Purdue Pegboard Test was available in 5,125 participants. The major-
ity ofmissing data for the Purdue Pegboard Testwas a result of physical
limitations of the participants, or due to violation of the test protocol
and was not related to RLS status.
2.3. Assessment of restless legs syndrome
RLS was assessed with a questionnaire, based on the Interna-
tional Restless Legs Syndrome Study Group (IRLSSG) 2003 criteria
[1], which are commonly used in epidemiological studies [6,33].
Three questions were asked: 1) “When sitting or lying still, do you
sometimes have unpleasant – crawling, itchy or burning – sensa-
tions in your calves or legs?” Answers included: “not during the last
month”, “less than once a week”, “once or twice a week” and “more
than twice a week”. 2) “Can these sensations only be relieved by
movement?” Answers included: “yes”, “no” and “not applicable”.
3) “Are these unpleasant sensations worse in the evening or at night
compared with during the day?” Answers included: “yes”, “no” and
“not applicable”. In order to meet the IRLSSG criteria for RLS, the
last two questions had to be answered positively. Participants who
answered “not during the last month” on the ﬁrst question or “no”
to the second or third question were considered as having no RLS.
The frequency of RLS symptoms was extracted from the answer
to the ﬁrst question. The urge to move the legs was not assessed
with the questionnaire.
2.4. Subjective assessment of physical functioning
Two standardized questionnaires were used to evaluate func-
tioning in activities of daily living: a Dutch version of the Stanford
Health Assessment Questionnaire [34] was used to assess basic ac-
tivities of daily living (BADL) and a Dutch version of the Instrumental
Activities of Daily Living scale [35] was used to evaluate instru-
mental activities of daily living (IADL).
The BADL disability score includes questions of locomotor ac-
tivities, ﬁne movements and other activities, involving both upper
and lower extremities. The score consists of 20 items within eight
components: dressing and grooming, arising, eating, walking,
hygiene, reach, grip, and activities [34,36]. Each item could be rated
from 0 to 3, with higher scores indicating worse ability (0 = no dif-
ﬁculty, 1 = some diﬃculty, 2 = much diﬃculty, 3 = unable to).
Component scores were calculated as the itemwith the highest score
(most severe disability) belonging to that component. The total dis-
ability score was calculated as the sum of the eight components
(range 0–24). A score of 0 to 8 reﬂects mild to moderate disability,
8 to 16 moderate to severe disability, and higher than 16 severe to
very severe disability [36].
The IADL scale contains a more complex set of activities: using
a telephone, shopping, food preparation, housekeeping, launder-
ing, transportation, medication maintenance, and management of
ﬁnances [35]. Consistent with BADL, these eight components were
scored from 0 to 3, with higher scores indicating worse ability. For
the IADL scale, 5.3% of the variables were scored as not applicable.
These values were imputed by multiple imputation using ﬁve it-
erations based on age, sex, the scores on all items of the BADL, and
the scores on the other available IADL items. The overall IADL score
was then calculated by summing the scores of the eight components.
2.5. Objective assessment of physical functioning
Physical functioning of arms and legs was assessed objectively
by quantifying gait with an electronic walkway and by quantify-
ing ﬁne motor performance with the Purdue Pegboard Test.
Gait was assessed with a 5.79 meter long walkway with pres-
sure sensors (4.88meter active area, GAITRite Platinum; CIR systems,
USA). Participants who visited the research center between March
2009 and December 2011 were asked to perform a standardized
walking protocol. Details about the gait assessment have been de-
scribed elsewhere [22]. In brief, the protocol consisted of normal
walk, turning and tandemwalk. In normal walk, participants walked
over the walkway at their own pace. This walk was recorded eight
times. To examine turning, the participants walked over the walkway
at their own pace, turned halfway, and returned to their starting
position (one recording). For tandemwalk, participants walked heel-
to-toe over a straight line visible on the walkway (one recording).
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The ﬁrst recording of the normal walk was treated as practice walk
and was not included in the analyses. The walkway software was
used to calculate 30 different spatiotemporal gait variables. Prin-
ciple component analysis (PCA) was used to summarize these
variables into seven independent gait factors (explaining 87.3% of
the total variance in gait), each representing a different gait domain:
Rhythm (stride time and cadence), Pace (stride length and veloci-
ty), Phases (percentage of time supporting on both feet compared
to one), Variability (variability in length and time among strides),
Base of Support (stride width and stride width variability), Tandem
(errors in tandemwalking), and Turning (time and amount of turning
steps), whichwere averaged into Global Gait.When necessary, factors
were inverted so that lower values indicate “poorer” gait. The PCA
yielded standardized factors (Z-scores) that were uncorrelated to
each other. Details about the PCA and the different domains have
been described elsewhere [22,25].
The Purdue Pegboard Test was used to assess ﬁne motor skills
of the upper extremities, also called manual dexterity [24]. The peg-
board has been widely used and proved to be a useful tool to detect
subtle motor dysfunction, especially in patients with early Parkin-
son’s disease [27,37,38]. The pegboard contains two parallel rows
with 25 holes. Participants were asked to place as many pins as pos-
sible into the holes within 30 seconds starting at the top row. This
test was repeated three times: ﬁrst with the preferred hand, next
with the other hand and ﬁnally with two hands simultaneously. The
number of correctly placed pins (in the ﬁrst two tests) or pairs of
pins (in the third test) is summed to calculate the ﬁnal score of the
test.
2.6. Additional measurements
The home interview comprised information about alcohol and
coffee consumption, smoking status, level of education, self-
reported osteoarthritis, depressive symptoms (assessed with the
Center for Epidemiologic Studies Depression scale, CES-D [39]) and
sleep quality (assessed with the Pittsburgh Sleep Quality Index [40],
PSQI). Alcohol use was assessed based on self-reported consump-
tion per month and converted into grams of ethanol per day.
Smoking was analyzed as current cigarette smoking versus non-
smoking (never and past smoking). Education was dichotomized in
primary education only or higher education (vocational and higher).
Medication use was assessed by self-report and by going through
the medication cabinets in the house. The examinations at the re-
search center included blood sampling (glucose and creatinine) and
measurement of height, weight and blood pressure. Bodymass index
was calculated by dividing a person’s weight by the square of their
height. Cardiovascular diseases (coronary heart disease and stroke)
were assessed through active follow-up and adjudicated using stan-
dardized deﬁnitions [41,42]. Diabetes mellitus was deﬁned as a
fasting glucose level >7.0 mmol/L, or use of anti-diabetic therapy.
Hypertensionwas deﬁned as amean systolic blood pressure (average
from two readings) above 140mmHg, diastolic blood pressure above
90 mmHg, or use of antihypertensive medication. Use of lipid low-
eringmedication was documented andmedication that is frequently
prescribed in RLS syndrome was also documented and combined
into one variable. This includes anti-Parkinson medication, such as
dopamine agonist, and anti-epileptics, such as pregabalin and
gabapentin.
2.7. Statistical analysis
We investigated the association between the presence of RLS and
subjective ADL functioning (BADL and IADL) with two different
analyses. First, we used multiple linear regression analysis to in-
vestigate the association of RLS with the continuous BADL and
IADL scores and scores on their separate components. Second, we
dichotomized BADL and IADL with a score between 0 and 8 (no to
moderate impairment) considered not impaired, and a score over
8 (moderate to very severe impairment) considered impaired. Binary
logistic regression analyses were then used to investigate the as-
sociation between RLS and impairment in BADL and IADL.
Additionally, we investigated the associations between frequency
of RLS symptoms and the BADL and IADL scores using analysis of
covariance (ANCOVA). Last, we performed sensitivity analysis, in-
vestigating the association of RLS with ADL restricting to participants
with both gait and manual dexterity data. The associations of RLS
(presence and frequency) with objective gait domains and the Purdue
Pegboard Test were investigatedwithmultiple linear regression anal-
ysis and analysis of covariance. We additionally performed an
analysis of covariance for the strongest correlated gait variables
within each gait domain. These variables can be easier to inter-
pret than the Z-scores that yielded from the PCA. Results for this
analysis are provided as supplement.
All analyses were adjusted for age, sex, body mass index, alcohol
use, smoking, coffee intake, diabetes mellitus, hypertension, stroke,
coronary heart disease, kidney function, osteoarthritis, lipid low-
ering medication, education, and RLS medication. Additionally, we
explored the effect of sleep and depressive symptoms by adjust-
ing the ADL analyses separately for these two factors. Gait analyses
were adjusted for height and weight instead of BMI to emphasize
the effect of height. Analyses involving tandem walking were ad-
ditionally adjusted for step length and step count in tandemwalking.
Differences between males and females were tested by adding in-
teraction terms to themodels. All statistical analyses were performed
using the SPSS statistical package, version 20.0 for Windows (IBM
Corp., Armonk, NY).
3. Results
In total 5,960 participants (57.5% females) were included in the
analyses. Age ranged from 46 to 98 years (46–55 years: 1048 sub-
jects, 18%; 56–65 years: 1445 subjects, 24%; 66–75 years: 1840
subjects, 31%; >75 years: 1627 subjects, 27%). RLS was present in
816 participants (13.7%). Prevalence of RLS was higher in females
than in males (18.3% compared to 7.5%). Age speciﬁc prevalence
showed a peak at age 55–60 of 17.0%. Participants with RLS were
younger and had worse scores on the PSQI and the CES-D than those
without RLS (Table 1). The mean BADL score in the entire popula-
tion was 3.06 (95% conﬁdence interval (CI) 2.97;3.16, range 0–24)
and the mean IADL score was 1.91 (95% CI 1.83;1.99, range 0–24).
3.1. Restless legs syndrome and subjectively assessed physical
functioning (Table 2)
When adjusting for multiple potential confounders, RLS was as-
sociated with higher BADL scores (0.65 points higher, 95% CI
0.41;0.90) and a higher probability of having impairment in BADL
(odds ratio 1.85, 95% CI 1.35;2.53), while RLS related to only small
differences in IADL score (0.28 points higher, 95% CI 0.09;0.48). No
association was found between RLS and having IADL impairment
(odds ratio 0.97, 95% CI 0.55;1.72). After adjusting for sleep quality
or depressive symptoms the associations between RLS and ADL at-
tenuated, both in BADL and IADL score and in BADL impairment
(Table 2). The effect of sleep quality was stronger for BADL, while
adjusting for depressive symptoms had a larger effect on IADL.
Individuals with RLS were more severely disabled in all com-
ponents of BADL and in the following three IADL components:
shopping, housekeeping, and transportation (see Supplementary
Table S1). However, after adjusting for sleep quality, most of these
associations attenuated strongly.
The associations were stronger for persons who experienced RLS
symptoms two or more times a week (Fig. 1 and Supplementary
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Table S2). Individuals with RLS symptomsmore than two days aweek
scored 1.69 points higher on BADL score (95% CI 1.28;2.09) than par-
ticipants without RLS and 0.77 points higher on IADL score (95%
CI 0.44;1.09). Adjustment for sleep quality and depressive symp-
toms slightly attenuated these associations too, but the results
remained signiﬁcant (Supplementary Table S2).
When restricting these analyses to the 2,341 participants with
all data available (RLS, ADL, gait and manual dexterity) similar as-
sociations were found (Supplementary Table S3).
No signiﬁcant sex-interaction terms were found in any of the
analyses.
3.2. Restless legs syndrome and objectively assessed physical
functioning (Table 3)
The prevalence of RLS in the subsample of participants with gait
assessment was 13.4%. RLS did not associate with any of the gait
domains, nor with the strongest correlated gait variable within each
gait domain (Supplementary Table S4). Higher frequency of RLS
symptoms was also not associated with gait (Supplementary
Table S2). Similarly, no associations were found between RLS and
Purdue Pegboard Test scores (Table 3 and Supplementary Table S2).
4. Discussion
In this population-based cohort study we found that RLS was
associated with more severe self-reported impairment in ADL, es-
pecially BADL. The effect of RLS on disability scores was most
pronounced in participants with RLS symptoms occurringmore than
two days a week. These associations attenuated after adjusting for
sleep quality or depressive symptoms. RLS was not associated with
either gait or scores on the Purdue Pegboard Test.
We found an association between RLS and subjective impair-
ment in physical functioning, even after adjusting for multiple
potential confounders. This is also reported in previous studies,
mainly concerning more vigorous activities, such as running and
climbing a set of stairs, and some components of ADL [2,7,11,13–20].
In our study, RLS was associated with all BADL components, and
with three out of eight IADL components: shopping, housekeep-
ing, and transportation, which are more physical items in this scale.
The reason for these associations remains unclear. It is possible that
sleep disturbance and depressive symptoms, which are often seen
in RLS patients and are associated with impairment in physical func-
tioning, are acting as intermediates. Indeed, when adjusting for these
variables, the associations between RLS and ADL weakened. Still,
this adjustment did not explain away the whole effect, suggesting
other potential explanations.
Other proposed explanations linking RLS with ADL include the
dopaminergic dysfunction, and more recently, autonomic dysfunc-
tion or abnormal activation of the central pattern generator, which
is a network of spinal neurons involved in the control of rhythmic
locomotor pattern generation and modulation [21,43,44]. In con-
trast to previous studies that investigated the association between
RLS and daily functioning, an innovative element of our study is that
we also assessed physical functioning with more objective mea-
sures. If impaired physical functioning is caused by an underlying
pathophysiological mechanism, changes in these objective mea-
surements would also be expected. However, we did not ﬁnd an
association of RLS with manual dexterity or gait, which is in ac-
cordance with the limited existing literature [45]. This implies that
the association of RLS with self-reported disability in activities of
daily living has no apparent pathophysiological explanation. However,
we note that this would only hold for the aspects of physical func-
tioning we captured with the assessment of gait and manual
dexterity. In other words, it remains possible that a pathophysi-
ological substrate explains the association of RLS with physical
function, but is not reﬂected in gait and manual dexterity.
Table 1
Characteristics of the study population.
Without restless
legs syndrome
n = 5,144
With restless
legs syndrome
n = 816
p-value
Age, years 67.3 (11.1) 66.6 (11.2) 0.02
Females, n 2798 (54.4) 627 (76.8) <0.01
Body mass index, kg/m2 27.5 (4.4) 27.8 (4.4) 0.23
Alcohol use, grams/day 6.9 (7.8) 5.8 (7.1) 0.64
Current smoking, n 788 (15.3) 137 (16.8) 0.63
Diabetes mellitus, n 575 (11.8) 84 (10.7) 0.88
Hypertension, n 3544 (70.2) 525 (65.0) 0.16
Prevalent coronary
heart disease, n
227 (4.5) 25 (3.1) 0.94
Prevalent stroke, n 184 (3.6) 25 (3.1) 0.88
Self-reported osteoarthritis, n 812 (15.8) 170 (20.8) 0.04
Lipid lowering medication, n 1451 (28.3) 222 (27.3) 0.39
Kidney function, GFR,
ml/min/1.73 m2
77.6 (17.1) 76.8 (18.0) <0.01
Coffee intake, cups/day 2.9 (2.0) 2.9 (2.0) 0.18
Primary education only, n 432 (8.5) 83 (10.3) 0.18
PSQI score 3.6 (3.4) 5.4 (4.1) <0.01
CES-D score 4.9 (6.8) 6.8 (7.7) <0.01
RLS medicationa, n 102 (2.0) 21 (2.6) 0.34
Values are number (%) for categorical variables or mean (standard deviation) for con-
tinuous variables. Percentages are calculated without missing values.
PSQI: Pittsburgh Sleep Quality Index, higher score indicates poorer sleep quality.
CES-D: Center for Epidemiological Studies Depression Scale, higher scores reﬂect more
depressive symptoms.
P-values are age and sex adjusted (if applicable).
a RLS medication includes use of anti-Parkinson medication and/or anti-epileptics.
Table 2
Association between the presence of restless legs syndrome and subjective physical functioning.
Basic activities of daily living Instrumental activities of daily living
Difference in score
(95% CI)
Odds ratio
(95% CI)
Difference in score
(95% CI)
Odds ratio
(95% CI)
Model 1 0.57 (0.32;0.82)** 1.38 (1.08;1.78)* 0.23 (0.02;0.44)* 0.90 (0.60;1.33)
Model 2 0.65 (0.41;0.90)** 1.85 (1.35;2.53)** 0.28 (0.09;0.48)** 0.97 (0.55;1.72)
Model 3 0.30 (0.04;0.55)* 1.30 (0.90;1.88) 0.21 (0.01;0.41)* 0.91 (0.47;1.75)
Model 4 0.45 (0.21;0.69)** 1.61 (1.15;2.25)** 0.16 (-0.03;0.35) 0.70 (0.37;1.33)
Values represent the difference in ADL (activities of daily living) score and odds ratios for impairment in ADL (95% conﬁdence intervals), between restless legs syndrome
(RLS) and no restless legs syndrome. Higher ADL scores reﬂect poorer ADL.
Model 1: adjusted for age and sex.
Model 2: adjusted for age, sex, body mass index, alcohol use, smoking, diabetes mellitus, education, hypertension, coronary heart disease, stroke, lipid lowering medica-
tion, osteoarthritis, coffee intake, GFR and RLS medication.
Model 3: Model 2, additionally adjusted for PSQI score.
Model 4: Model 2, additionally adjusted for CES-D score.
* p < 0.05, **p < 0.01.
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Another reason for the discrepancy in our results between sub-
jective and objective assessment of physical functioning could be
due to methodological issues. We assessed RLS with a question-
naire that included a frequency measure, but no severity measure.
Severely affected participants may have more impairment in their
physical functioning that wewere not able to assess. This might have
led to an underestimation of the true impact of RLS on physical func-
tioning. It is also possible that the measurements we used to assess
objective physical functioning were not the most suitable tests to
detect potential changes in motor function in RLS patients. More-
over, the objective assessments were performed only once, and since
RLS symptoms occur intermittently, it is possible that the assess-
ment was not performed during a symptomatic period. Alternatively,
the discrepancy could be because both RLS and ADL are assessed
by means of a questionnaire examined by the same interviewer.
Therefore, it is possible that part of the associations we found
between RLS and ADL are the result of common method bias [46].
The associations of RLS with gait and manual dexterity may thus
be more reliable as they are measured independently.
We found that the association of RLS with physical functioning
attenuated after adjustment for CES-D and sleep quality. This sug-
gests that the associations we found for RLS with self-reported
disability are at least partly a reﬂection of a person’s general well-
being or quality of life. The lack of sleep and presence of depressive
symptoms accompanying RLS may inﬂuence an individual’s per-
ception of his physical functioning. This highlights the importance
of recognition of both RLS and the accompanying sleep or mood dis-
turbances. Improving sleep quality and treating mood disorders in
patients with RLS may have a beneﬁcial effect on an individual’s
quality of life.
The strengths of our study include the population-based design,
large number of participants, inclusion of symptom frequency into
our analyses and, unlike other studies, use of both subjective
and objective measurements of physical functioning. There are also
Fig. 1. Frequency of RLS symptoms and activities of daily living scores.
Mean adjusted ADL scores per frequency of RLS symptoms. Error bars represent the 95% conﬁdence interval around the mean.
A: Basic activities of daily living.
B: Instrumental activities of daily living
Model 1: adjusted for age, sex, body mass index, alcohol use, smoking, diabetes mellitus, education, hypertension, coronary heart disease, stroke, lipid lowering medica-
tion, osteoarthritis, coffee intake, GFR and RLS medication
Model 2: model 1, additionally adjusted for sleep quality (PSQI)
Model 3: model 1, additionally adjusted for depressive symptoms (CES-D)
Table 3
Association between the presence of restless legs syndrome and objective physical functioning.
Gait domains Manual dexterity
Rhythm Variability Phases Pace Base of Support Turning Tandema Global Gait Purdue Pegboard
Model 1 −0.05
(−0.15;0.06)
0.02
(−0.09;0.13)
0.06
(−0.05;0.18)
−0.05
(−0.15;0.05)
0.04
(−0.07;0.16)
0.00
(−0.12;0.11)
0.06
(−0.06;0.19)
0.02
(−0.08;0.13)
0.18
(−0.15;0.52)
Model 2 0.01
(−0.11;0.12)
0.01
(−0.11;0.14)
0.09
(−0.01;0.20)
0.00
(−0.10;0.10)
−0.01
(−0.14;0.11)
0.02
(−0.11;0.14)
0.04
(−0.10;0.18)
0.05
(−0.06;0.17)
0.24
(−0.13;0.61)
Values for gait domains represent difference in Z-score (with 95% conﬁdence interval) between restless legs syndrome (RLS) compared to no RLS. Lower values indicate
poorer gait.
Values for the Purdue Pegboard Test represent difference in correctly placed pins between RLS compared to no RLS.
Higher numbers represent better performance.
Model 1: adjusted for age, sex.
Model 2: adjusted for age, sex, height, weight, alcohol use, smoking, diabetes mellitus, education, hypertension, coronary heart disease, stroke, lipid lowering medication,
osteoarthritis, coffee intake, GFR and RLS medication.
a Additionally adjusted for step length and step count in tandem walk.
In all the analyses p-values were above 0.05.
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limitations to our work. An important limitation of our study is that
the questionnaire did not incorporate the urge to move the legs,
which is an essential criterion for the diagnosis of RLS. We as-
sessed presence of uncomfortable sensation in the legs, which are
not always present in patients with RLS. People who do not feel the
urge, but do have these sensations may have been considered as
RLS positives. This might have led to an overestimation of the prev-
alence. Prevalence can also be underestimated, because people with
the urge but without these sensations are considered as RLS neg-
ative. This misclassiﬁcation could have led to a dilution of the
association. Other essential RLS criteria are met in our case deﬁ-
nition. Another limitation of the questionnaire is that it did not assess
the severity of RLS symptoms. Although we used information about
the frequency of symptoms, which might not totally reﬂect clini-
cally relevant RLS, this could have inﬂuenced our ﬁndings leading
to an underestimation of the effect of RLS on physical functioning.
We only investigated the associations between RLS and physical func-
tioning cross-sectionally. Diagnosis of RLS is based on self-reported
symptoms without a neurological examination and although the
IRLSSG criteria were used, secondary RLS or RLS mimics, such as
peripheral neuropathy or leg cramps, could not be excluded with
our questionnaire. This may have led to an overestimation of the
prevalence. The prevalence of RLS in our study is high, but corre-
sponds to prevalence reported in some other studies investigating
an aged population, especially in countries from Northern Europe
[2,47]. Information regarding other potential confounders like Par-
kinson’s Disease, andmedications that might be associated with RLS
were not systematically assessed, so we could not investigate
whether this inﬂuenced our results. We used gait and manual dex-
terity as tests to quantify motor performance, but this probably
covers only part, and possibly other aspects of physical function-
ing. A last limitation is that data about gait and manual dexterity
was not available for the entire study sample, but we did not have
any indication for selection biases. Moreover, our sensitivity anal-
ysis yielded similar results as the main analysis.
To conclude, in our community-dwelling population of middle-
aged and older people, we found RLS to associate with self-
reported impairment in daily functioning. We did not ﬁnd an
association between RLS and gait or manual dexterity. This indi-
cates that impairment in basic ADL does not originate from a
pathophysiological mechanism that affects motor performance.
However, there may be processes involved that are not covered by
ourmeasurements of gait andmanual dexterity. Moreover, we found
that the association between RLS attenuated after adjusting for sleep
or mood disturbance, indicating that at least part of the associa-
tion can be explained by a person’s general well-being or quality
of life.
Acknowledgements
Financial disclosures
R. Hanewinckel reports no disclosures.
A. Maksimovic reports no disclosures.
V.J.A.Verlinden reports no disclosures.
J.N. van der Geest reports no disclosures.
A. Hofman received grants from the Netherlands Organization
for Scientiﬁc Research, the Netherlands Genomics Initiative, the Neth-
erlands Ministry of Health and the European Commission; and
remuneration as editor of the European Journal of Epidemiology.
P.A. van Doorn received a grant from the Prinses Beatrix
Spierfonds for neuromuscular diseases (grant number W.OR12-08).
A.J.W. Boon reports no disclosures.
H. Tiemeier received funding by the Netherlands Organization
for Scientiﬁc Research (grant number NWO-VIDI: 017.106.370).
M.A. Ikram received grants from the Netherlands Heart Foun-
dation (2009B102 and 2012T008), Netherlands Organization for
Health Research and Development (ZonMW: 916.13.054),
Internationaal Parkinson Fonds, and Internationale Stichting Al-
zheimer Onderzoek (#12533).
Funding
The Rotterdam Study is supported by the Erasmus MC Univer-
sity Medical Center and Erasmus University Rotterdam; the
Netherlands Organization for Scientiﬁc Research (NWO); The Neth-
erlands Organization for Health Research and Development
(ZonMW); the Research Institute for Diseases in the Elderly (RIDE);
the Netherlands Genomics Initiative (NGI); the Ministry of Educa-
tion, Culture and Science; theMinistry of Health,Welfare and Sports;
the European Commission (DG XII); and the Municipality of Rot-
terdam. Further support was obtained from the Netherlands
Consortium for Healthy Ageing (NCHA); and by a grant from the
Netherlands Organization for Health Research and Development
(ZonMw) [grant 80-82500-98-10208]. None of the funding orga-
nizations or sponsors were involved in the design and conduct of
the study; collection, management analysis, and interpretation of
the data; and preparation, review, or approval of the manuscript.
Conﬂicts of interest
The ICMJE Uniform Disclosure Form for Potential Conﬂicts of In-
terest associated with this article can be viewed by clicking on the
following link: http://dx.doi.org/10.1016/j.sleep.2014.11.013.
Appendix: Supplementary material
Supplementary data to this article can be found online at
doi:10.1016/j.sleep.2014.11.013.
References
[1] Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic
criteria, special considerations, and epidemiology. A report from the restless
legs syndrome diagnosis and epidemiology workshop at the National Institutes
of Health. Sleep Med 2003;4:101–19.
[2] Yeh P, Walters AS, Tsuang JW. Restless legs syndrome: a comprehensive
overview on its epidemiology, risk factors, and treatment. Sleep Breath
2012;16:987–1007.
[3] Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome
(RLS). Sleep Med 2004;5:385–91.
[4] Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord
2007;22(Suppl. 18):S440–8.
[5] Dauvilliers Y, Winkelmann J. Restless legs syndrome: update on pathogenesis.
Curr Opin Pulm Med 2013;19:594–600.
[6] Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk
factors of RLS in an elderly population: theMEMO study. Memory andMorbidity
in Augsburg Elderly. Neurology 2000;54:1064–8.
[7] Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence
and impact: REST general population study. Arch InternMed 2005;165:1286–92.
[8] Bjorvatn B, Leissner L, Ulfberg J, et al. Prevalence, severity and risk factors of
restless legs syndrome in the general adult population in two Scandinavian
countries. Sleep Med 2005;6:307–12.
[9] Tison F, Crochard A, Leger D, Bouee S, Lainey E, El Hasnaoui A. Epidemiology
of restless legs syndrome in French adults: a nationwide survey: the INSTANT
Study. Neurology 2005;65:239–46.
[10] Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K. Epidemiology of restless
legs syndrome: the current status. Sleep Med Rev 2006;10:153–67.
[11] Innes KE, Selfe TK, Agarwal P. Prevalence of restless legs syndrome in North
American andWestern European populations: a systematic review. Sleep Med
2011;12:623–34.
[12] Ohayon MM, O’Hara R, Vitiello MV. Epidemiology of restless legs syndrome:
a synthesis of the literature. Sleep Med Rev 2012;16:283–95.
[13] Abetz L, Allen R, Follet A, et al. Evaluating the quality of life of patients with
restless legs syndrome. Clin Ther 2004;26:925–35.
[14] HeningW,Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact,
diagnosis and treatment of restless legs syndrome (RLS) in a primary care
population: the REST (RLS epidemiology, symptoms, and treatment) primary
care study. Sleep Med 2004;5:237–46.
[15] Garcia-Borreguero D. Time to REST: epidemiology and burden. Eur J Neurol
2006;13(Suppl. 3):15–20.
404 R. Hanewinckel et al./Sleep Medicine 16 (2015) 399–405
[16] Kohnen R, Allen RP, Benes H, et al. Assessment of restless legs syndrome–
methodological approaches for use in practice and clinical trials. Mov Disord
2007;22(Suppl. 18):S485–94.
[17] Reese JP, Stiasny-Kolster K, Oertel WH, Dodel RC. Health-related quality of life
and economic burden in patients with restless legs syndrome. Expert Rev
Pharmacoecon Outcomes Res 2007;7:503–21.
[18] Happe S, Reese JP, Stiasny-Kolster K, et al. Assessing health-related quality of
life in patients with restless legs syndrome. Sleep Med 2009;10:295–305.
[19] Lasch KE, Abraham L, Patrick J, Piault EC, Tully SE, Treglia M. Development of
a next day functioning measure to assess the impact of sleep disturbance due
to restless legs syndrome: the restless legs syndrome-next day impact
questionnaire. Sleep Med 2011;12:754–61.
[20] Cirillo DJ, Wallace RB. Restless legs syndrome and functional limitations among
American elders in the Health and Retirement Study. BMC Geriatr 2012;12:39.
[21] Zhang C, Li Y, Malhotra A, Ning Y, Gao X. Restless legs syndrome status as a
predictor for lower physical function. Neurology 2014;82:1212–18.
[22] Verlinden VJ, van der Geest JN, Hoogendam YY, Hofman A, Breteler MM, Ikram
MA. Gait patterns in a community-dwelling population aged 50 years and older.
Gait Posture 2013;37:500–5.
[23] Hollman JH, McDade EM, Petersen RC. Normative spatiotemporal gait
parameters in older adults. Gait Posture 2011;34:111–18.
[24] Desrosiers J, Hebert R, Bravo G, Dutil E. The Purdue Pegboard Test: normative
data for people aged 60 and over. Disabil Rehabil 1995;17:217–24.
[25] Verlinden VJ, van der Geest JN, Hofman A, Ikram MA. Cognition and gait show
a distinct pattern of association in the general population. Alzheimers Dement
2014;10:328–35.
[26] Lord S, Howe T, Greenland J, Simpson L, Rochester L. Gait variability in older
adults: a structured review of testing protocol and clinimetric properties. Gait
Posture 2011;34:443–50.
[27] Haaxma CA, Bloem BR, Overeem S, Borm GF, Horstink MW. Timed motor tests
can detect subtle motor dysfunction in early Parkinson’s disease. Mov Disord
2010;25:1150–6.
[28] Postuma RB, Lang AE, Gagnon JF, Pelletier A, Montplaisir JY. How does
parkinsonism start? Prodromal parkinsonismmotor changes in idiopathic REM
sleep behaviour disorder. Brain 2012;135:1860–70.
[29] Onder G, Penninx BW, Ferrucci L, Fried LP, Guralnik JM, Pahor M. Measures of
physical performance and risk for progressive and catastrophic disability: results
from the Women’s Health and Aging Study. J Gerontol A Biol Sci Med Sci
2005;60:74–9.
[30] Verlinden VJ, van der Geest JN, Heeringa J, Hofman A, Ikram MA. Gait shows a
sex-speciﬁc pattern of associations with daily functioning in a community-
dwelling population of older people. Gait Posture 2015;41:119–24.
[31] Todd G, Haberﬁeld M, Faulkner PL, et al. Upper limb function is normal in
patients with restless legs syndrome (Willis-Ekbom Disease). Clin Neurophysiol
2014;00396–4.
[32] Hofman A, Darwish Murad S, van Duijn CM, et al. The Rotterdam Study: 2014
objectives and design update. Eur J Epidemiol 2013;28:889–926.
[33] Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of
restless legs syndrome in the general population. Arch Intern Med
2004;164:196–202.
[34] Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health
assessment questionnaire, disability and pain scales. J Rheumatol 1982;9:789–
93.
[35] Lawton MP, Brody EM. Assessment of older people: self-maintaining and
instrumental activities of daily living. Gerontologist 1969;9:179–86.
[36] Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of
its history, issues, progress, and documentation. J Rheumatol 2003;30:167–78.
[37] Muller T, Benz S. Quantiﬁcation of the dopaminergic response in Parkinson’s
disease. Parkinsonism Relat Disord 2002;8:181–6.
[38] Adler CH, Hentz JG, Joyce JN, Beach T, Caviness JN. Motor impairment in normal
aging, clinically possible Parkinson’s disease, and clinically probable Parkinson’s
disease: longitudinal evaluation of a cohort of prospective brain donors.
Parkinsonism Relat Disord 2002;9:103–10.
[39] Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing
depressive symptoms in ﬁve psychiatric populations: a validation study. Am J
Epidemiol 1977;106:203–14.
[40] Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh
Sleep Quality Index: a new instrument for psychiatric practice and research.
Psychiatry Res 1989;28:193–213.
[41] Wieberdink RG, Ikram MA, Hofman A, Koudstaal PJ, Breteler MM. Trends in
stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands
from 1990 to 2008. Eur J Epidemiol 2012;27:287–95.
[42] Leening MJ, Kavousi M, Heeringa J, et al. Methods of data collection and
deﬁnitions of cardiac outcomes in the Rotterdam Study. Eur J Epidemiol
2012;27:173–85.
[43] Guertin PA. Central pattern generator for locomotion: anatomical, physiological,
and pathophysiological considerations. Front Neurol 2012;3:183.
[44] Takakusaki K. Neurophysiology of gait: from the spinal cord to the frontal lobe.
Mov Disord 2013;28:1483–91.
[45] Jimenez-Jimenez FJ, Rubio L, Calleja M, et al. Motor performance in patients
with restless legs syndrome. Mov Disord 2009;24:1656–61.
[46] Podsakoff PM, MacKenzie SB, Podsakoff NP. Sources of method bias in social
science research and recommendations on how to control it. Annu Rev Psychol
2012;63:539–69.
[47] Juuti AK, Laara E, Rajala U, et al. Prevalence and associated factors of restless
legs in a 57-year-old urban population in northern Finland. Acta Neurol Scand
2010;122:63–9.
405R. Hanewinckel et al./Sleep Medicine 16 (2015) 399–405
